Copyright Reports & Markets. All rights reserved.

Global Nuclear Medicine & Radiopharmaceuticals Sales Market Report 2021

Request for Sample of this report
Buy now

1 Nuclear Medicine & Radiopharmaceuticals Market Overview

  • 1.1 Nuclear Medicine & Radiopharmaceuticals Product Scope
  • 1.2 Nuclear Medicine & Radiopharmaceuticals Segment by Type
    • 1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Diagnostic Radioisotopes
    • 1.2.3 Therapeutic Radioisotopes
  • 1.3 Nuclear Medicine & Radiopharmaceuticals Segment by Application
    • 1.3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Oncology
    • 1.3.3 Cardiology
    • 1.3.4 Other
  • 1.4 Nuclear Medicine & Radiopharmaceuticals Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Nuclear Medicine & Radiopharmaceuticals Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Nuclear Medicine & Radiopharmaceuticals Price Trends (2016-2027)

2 Nuclear Medicine & Radiopharmaceuticals Estimates and Forecasts by Region

  • 2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Nuclear Medicine & Radiopharmaceuticals Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
  • 2.3 Global Nuclear Medicine & Radiopharmaceuticals Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Nuclear Medicine & Radiopharmaceuticals Estimates and Projections (2016-2027)
    • 2.4.2 Europe Nuclear Medicine & Radiopharmaceuticals Estimates and Projections (2016-2027)
    • 2.4.3 China Nuclear Medicine & Radiopharmaceuticals Estimates and Projections (2016-2027)
    • 2.4.4 Japan Nuclear Medicine & Radiopharmaceuticals Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Estimates and Projections (2016-2027)
    • 2.4.6 India Nuclear Medicine & Radiopharmaceuticals Estimates and Projections (2016-2027)

3 Global Nuclear Medicine & Radiopharmaceuticals Competition Landscape by Players

  • 3.1 Global Top Nuclear Medicine & Radiopharmaceuticals Players by Sales (2016-2021)
  • 3.2 Global Top Nuclear Medicine & Radiopharmaceuticals Players by Revenue (2016-2021)
  • 3.3 Global Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Medicine & Radiopharmaceuticals as of 2020)
  • 3.4 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Company (2016-2021)
  • 3.5 Manufacturers Nuclear Medicine & Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Type

  • 4.1 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2016-2021)
  • 4.2 Global Nuclear Medicine & Radiopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Nuclear Medicine & Radiopharmaceuticals Price Forecast by Type (2022-2027)

5 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Application

  • 5.1 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2016-2021)
  • 5.2 Global Nuclear Medicine & Radiopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Nuclear Medicine & Radiopharmaceuticals Price Forecast by Application (2022-2027)

6 North America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures

  • 6.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Company
    • 6.1.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Company (2016-2021)
    • 6.1.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021)
  • 6.2 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
    • 6.2.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
  • 6.3 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application
    • 6.3.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2022-2027)

7 Europe Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures

  • 7.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Company
    • 7.1.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Company (2016-2021)
    • 7.1.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021)
  • 7.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
    • 7.2.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application
    • 7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)

8 China Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures

  • 8.1 China Nuclear Medicine & Radiopharmaceuticals Sales by Company
    • 8.1.1 China Nuclear Medicine & Radiopharmaceuticals Sales by Company (2016-2021)
    • 8.1.2 China Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021)
  • 8.2 China Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
    • 8.2.1 China Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
  • 8.3 China Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application
    • 8.3.1 China 163 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 163 Sales Breakdown by Application (2022-2027)

9 Japan Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures

  • 9.1 Japan Nuclear Medicine & Radiopharmaceuticals Sales by Company
    • 9.1.1 Japan Nuclear Medicine & Radiopharmaceuticals Sales by Company (2016-2021)
    • 9.1.2 Japan Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021)
  • 9.2 Japan Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
    • 9.2.1 Japan Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures

  • 10.1 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales by Company
    • 10.1.1 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
    • 10.2.1 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures

  • 11.1 India Nuclear Medicine & Radiopharmaceuticals Sales by Company
    • 11.1.1 India Nuclear Medicine & Radiopharmaceuticals Sales by Company (2016-2021)
    • 11.1.2 India Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021)
  • 11.2 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
    • 11.2.1 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
  • 11.3 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application
    • 11.3.1 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Nuclear Medicine & Radiopharmaceuticals Business

  • 12.1 Bracco Imaging
    • 12.1.1 Bracco Imaging Corporation Information
    • 12.1.2 Bracco Imaging Business Overview
    • 12.1.3 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Products Offered
    • 12.1.5 Bracco Imaging Recent Development
  • 12.2 Bayer
    • 12.2.1 Bayer Corporation Information
    • 12.2.2 Bayer Business Overview
    • 12.2.3 Bayer Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Bayer Nuclear Medicine & Radiopharmaceuticals Products Offered
    • 12.2.5 Bayer Recent Development
  • 12.3 Mallinckrodt
    • 12.3.1 Mallinckrodt Corporation Information
    • 12.3.2 Mallinckrodt Business Overview
    • 12.3.3 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Products Offered
    • 12.3.5 Mallinckrodt Recent Development
  • 12.4 Nordion
    • 12.4.1 Nordion Corporation Information
    • 12.4.2 Nordion Business Overview
    • 12.4.3 Nordion Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Nordion Nuclear Medicine & Radiopharmaceuticals Products Offered
    • 12.4.5 Nordion Recent Development
  • 12.5 Triad Isotopes
    • 12.5.1 Triad Isotopes Corporation Information
    • 12.5.2 Triad Isotopes Business Overview
    • 12.5.3 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Products Offered
    • 12.5.5 Triad Isotopes Recent Development
  • 12.6 Lantheus
    • 12.6.1 Lantheus Corporation Information
    • 12.6.2 Lantheus Business Overview
    • 12.6.3 Lantheus Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Lantheus Nuclear Medicine & Radiopharmaceuticals Products Offered
    • 12.6.5 Lantheus Recent Development
  • 12.7 IBA Group
    • 12.7.1 IBA Group Corporation Information
    • 12.7.2 IBA Group Business Overview
    • 12.7.3 IBA Group Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 IBA Group Nuclear Medicine & Radiopharmaceuticals Products Offered
    • 12.7.5 IBA Group Recent Development
  • 12.8 GE Healthcare
    • 12.8.1 GE Healthcare Corporation Information
    • 12.8.2 GE Healthcare Business Overview
    • 12.8.3 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Products Offered
    • 12.8.5 GE Healthcare Recent Development
  • 12.9 China Isotope & Radiation
    • 12.9.1 China Isotope & Radiation Corporation Information
    • 12.9.2 China Isotope & Radiation Business Overview
    • 12.9.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Products Offered
    • 12.9.5 China Isotope & Radiation Recent Development
  • 12.10 Jubilant Pharma
    • 12.10.1 Jubilant Pharma Corporation Information
    • 12.10.2 Jubilant Pharma Business Overview
    • 12.10.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Products Offered
    • 12.10.5 Jubilant Pharma Recent Development
  • 12.11 Eli Lilly
    • 12.11.1 Eli Lilly Corporation Information
    • 12.11.2 Eli Lilly Business Overview
    • 12.11.3 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Products Offered
    • 12.11.5 Eli Lilly Recent Development
  • 12.12 Advanced Accelerator Applications
    • 12.12.1 Advanced Accelerator Applications Corporation Information
    • 12.12.2 Advanced Accelerator Applications Business Overview
    • 12.12.3 Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Products Offered
    • 12.12.5 Advanced Accelerator Applications Recent Development
  • 12.13 SIEMENS
    • 12.13.1 SIEMENS Corporation Information
    • 12.13.2 SIEMENS Business Overview
    • 12.13.3 SIEMENS Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 SIEMENS Nuclear Medicine & Radiopharmaceuticals Products Offered
    • 12.13.5 SIEMENS Recent Development
  • 12.14 Dongcheng
    • 12.14.1 Dongcheng Corporation Information
    • 12.14.2 Dongcheng Business Overview
    • 12.14.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Products Offered
    • 12.14.5 Dongcheng Recent Development
  • 12.15 Navidea
    • 12.15.1 Navidea Corporation Information
    • 12.15.2 Navidea Business Overview
    • 12.15.3 Navidea Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Navidea Nuclear Medicine & Radiopharmaceuticals Products Offered
    • 12.15.5 Navidea Recent Development

13 Nuclear Medicine & Radiopharmaceuticals Manufacturing Cost Analysis

  • 13.1 Nuclear Medicine & Radiopharmaceuticals Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
  • 13.4 Nuclear Medicine & Radiopharmaceuticals Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Nuclear Medicine & Radiopharmaceuticals Distributors List
  • 14.3 Nuclear Medicine & Radiopharmaceuticals Customers

15 Market Dynamics

  • 15.1 Nuclear Medicine & Radiopharmaceuticals Market Trends
  • 15.2 Nuclear Medicine & Radiopharmaceuticals Drivers
  • 15.3 Nuclear Medicine & Radiopharmaceuticals Market Challenges
  • 15.4 Nuclear Medicine & Radiopharmaceuticals Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Nuclear Medicine & Radiopharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Medicine & Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Diagnostic Radioisotopes
    Therapeutic Radioisotopes

    Segment by Application
    Oncology
    Cardiology
    Other

    The Nuclear Medicine & Radiopharmaceuticals market is analysed and market size information is provided by regions (countries). Segment by Application, the Nuclear Medicine & Radiopharmaceuticals market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Bracco Imaging
    Bayer
    Mallinckrodt
    Nordion
    Triad Isotopes
    Lantheus
    IBA Group
    GE Healthcare
    China Isotope & Radiation
    Jubilant Pharma
    Eli Lilly
    Advanced Accelerator Applications
    SIEMENS
    Dongcheng
    Navidea

    Buy now